25 March 2025

Wellnex Life Limited

("Wellnex Life" or the "Company")

Issue of Equity - Pain Away vendor shares

Wellnex Life Limited (AIM: WNX | ASX: WNX), an innovative brand and distribution company focused on consumer health and wellness products, announces that application has been made for the admission to trading on AIM of 403,226 new ordinary shares of no par value ("Ordinary Shares") which have been issued in connection with the settlement of the deferred consideration which has been settled with the Pain Away vendors. The new Ordinary Shares will rank pari passu in all respects with the Company's issued Ordinary Shares and dealings are expected to commence on or around 26 March 2025.

Following Admission, the Company's issued share capital will comprise of 66,637,159 Ordinary Shares, none of which are held in treasury. Accordingly, the figure of 66,637,159 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure Guidance and Transparency Rules and the provisions of the Company's constitution.

Enquiries: